Evidence-based review of bronchoscopic lung volume reduction.
Juvva Kishan SrikanthNitesh GuptaHari Kishan GonuguntlaHari Kishan GonuguntlaPublished in: Advances in respiratory medicine (2021)
Emphysema sequentially leads to the loss of gas exchanging surface and an abnormal shape of the diaphragm generating dyspnea refractory to standard medical therapy. Lung volume reduction surgery (LVRS) is a surgical treatment option for patients with severe emphysema whose symptoms are uncontrolled on standard therapy. Bronchoscopic LVR (bLVR) is a process by which lung volume reduction is achieved in a minimally invasive manner using bronchoscopy-guided insertion of valves, coils, sealants, or by thermal vapour ablation like techniques. These therapies have developed over the last few years and have variable results in patients. We have summarized the current evidence available on each of these methods in this review.
Keyphrases
- minimally invasive
- end stage renal disease
- chronic obstructive pulmonary disease
- newly diagnosed
- ejection fraction
- lung function
- chronic kidney disease
- healthcare
- idiopathic pulmonary fibrosis
- coronary artery bypass
- stem cells
- depressive symptoms
- patient reported outcomes
- robot assisted
- acute coronary syndrome
- intensive care unit
- coronary artery disease
- cystic fibrosis
- mechanical ventilation
- aortic valve
- bone marrow
- patient reported
- extracorporeal membrane oxygenation
- ionic liquid
- drug induced
- carbon dioxide
- replacement therapy